资料显示，名仕快相集团控股有限公司仍为香港及广东省领先的自助身份证明("身份证明")照片数码快 相机营运商,于两地分别运营公司的标志性品牌"Max Sight Photo名仕快相"及"名仕富美"。此外,公司亦 透过于香港经营医务中心开展医疗服务业务,从而多元化发展本集团的业务及扩大其收益来源。摄影服 务业务:公司的摄影服务业务旨在向客户提供"精准验证、简单照片"的优质照片服务。公司向香港及广 东省的客户提供"无条件担保",倘客户因任何原因而不满意由公司营运的自助数码快相机拍摄的照片,公 司将于客户退回所拍摄的相片后提供免费重拍直至客户满意或全额退款。公司相信"无条件担保"能提高 客户对公司产品的信心。公司的目标客户为大众消费者,而公司在香港及广东省的客户群庞大且多元 化。公司的照片数码快相机策略性地位于人流量大的黄金地段和/或可能对身份证明照片有需求的地方, 包括香港和广东省的身份证件签发机构、铁路和机场、多所大学、医院和购物中心。本集团将不断重新 评估每个照片数码快相机位置的盈利能力,并相应地重新安置照片数码快相机。医疗服务业务:由于公众 的健康意识不断提高,公司认为对优质医疗服务的需求将会稳定增长。公司致 ...

香 港 交 易 及 結 算 所 有 限 公 司 及 香 港 聯 合 交 易 所 有 限 公 司（「聯 交 所」）對 本 公 告 的 內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示 概 不 就 因 本 公 告 全 部 或 任 何 部 分 內 容 而 產 生 或 因 倚 賴 該 等 內 容 而 引 致 的 任 何 損 失 承 擔 任 何 責 任。 本 公 告 載 有 遵 照 聯 交 所GEM證 券 上 市 規 則（「GEM上 市 規 則」）提 供 的 詳 情， 旨在提供關於名仕快相集團控股有限公司（「本公司」）的資料，本公司董事（「董 事」）就 此 共 同 及 個 別 地 承 擔 全 部 責 任。董 事 經 作 出 一 切 合 理 查 詢 後 確 認， 就 彼 等 所 深 知 及 確 信，本 公 告 所 載 資 料 在 所 有 重 大 方 面 均 屬 準 確 及 完 整， 並 無 誤 導 或 欺 詐 成 分，且 本 公 告 並 無 遺 漏 任 何 其 他 事 宜 導 致 當 中 任 何 陳 述 或 本 公 告 具 誤 導 成 分。 Max Sight ...

Revenue Performance - The group's revenue for the six months ended June 30, 2024, decreased by approximately HKD 4,903,000 to about HKD 34,574,000, compared to HKD 39,477,000 for the same period in 2023[12]. - Revenue from the photography services segment decreased by approximately 29.50% to about HKD 23,441,000, down from HKD 33,249,000 in the previous year[12]. - Revenue from the medical services segment increased by approximately 78.76% to about HKD 11,133,000, compared to HKD 6,228,000 for the same period in 2023[12]. - Total revenue for the six months ended June 30, 2024, was HKD 34,574,000, a decrease of 12% from HKD 39,477,000 in the same period of 2023[37]. - Photography service revenue was HKD 23,441,000, down 29% from HKD 33,249,000 year-on-year[37]. - Medical service revenue increased significantly to HKD 11,133,000, up 79% from HKD 6,228,000 in the previous year[37]. - For the six months ended June 30, 2024, the total revenue from external customers was HKD 34,574,000, a decrease of 12.1% compared to HKD 39,477,000 for the same period in 2023[44]. - The group reported a total of HKD 1,935,000 in non-current assets for deposits related to utilities as of June 30, 2024, down from HKD 2,255,000 in December 2023[62]. Profitability and Loss - The group's gross profit for the six months ended June 30, 2024, was approximately HKD 10,839,000, with a gross profit margin of about 31.35%, compared to HKD 13,056,000 and 33.07% in the previous year[12]. - The loss attributable to equity shareholders for the six months ended June 30, 2024, was approximately HKD 199,000, compared to a profit of HKD 3,708,000 for the same period in 2023[12]. - Operating profit for the six months ended June 30, 2024, was HKD 739,000, down from HKD 3,956,000 in the previous year[15]. - The profit before tax for the six months ended June 30, 2024, was HKD 392,000, compared to HKD 3,677,000 in the previous year[15]. - The company reported a net profit of HKD 252,000 for the period, down from HKD 3,733,000 in the previous year[15]. - Total comprehensive income for the six months ended June 30, 2024, was HKD 434,000, compared to HKD 4,084,000 for the same period in 2023, representing a decrease of approximately 89.4%[17]. - Basic and diluted earnings per share for the period were (0.02) HKD, down from 0.46 HKD in the previous year[17]. - The company reported a basic loss attributable to equity shareholders of approximately HKD 199,000 for the six months ended June 30, 2024, compared to a profit of approximately HKD 3,708,000 for the same period in 2023[56]. Cash Flow and Assets - Cash and bank balances increased from HKD 20,669,000 to HKD 24,919,000, an increase of about 20.9%[19]. - Operating cash flow for the six months ended June 30, 2024, was HKD 6,292,000, slightly down from HKD 6,496,000 in the same period last year[24]. - The company reported a net cash inflow of HKD 4,061,000 for the six months ended June 30, 2024, compared to HKD 3,349,000 in the same period of 2023[26]. - Cash and cash equivalents at the end of the period were HKD 24,919,000, up from HKD 20,333,000 at the end of June 2023, reflecting a net increase of HKD 4,061,000[26]. - The company recorded a decrease in trade receivables from HKD 2,854,000 to HKD 2,160,000, a reduction of approximately 24.3%[19]. - Current assets decreased from HKD 31,265,000 to HKD 30,200,000, a reduction of approximately 3.4%[19]. - Non-current assets decreased from HKD 23,175,000 as of December 31, 2023, to HKD 19,753,000 as of June 30, 2024, a decline of about 14.5%[19]. - The company has stored all unutilized net proceeds in licensed banks in Hong Kong as of the date of the mid-term report[127]. Liabilities and Equity - The company’s total liabilities increased from HKD 16,020,000 to HKD 17,222,000, an increase of about 7.5%[19]. - The total equity of the group was approximately HKD 23,879,000 as of June 30, 2024, down from HKD 26,798,000 as of June 30, 2023[93]. - The debt-to-asset ratio increased to 52.20% as of June 30, 2024, from 49.52% as of June 30, 2023[93]. - The company had no outstanding bank loans as of June 30, 2024, compared to HKD 2,000,000 on June 30, 2023[93]. Operational Developments - The company operates primarily in two segments: photography services in Hong Kong and mainland China, and medical services in Hong Kong[39]. - The group is reallocating resources to develop its medical services business, including purchasing equipment and upgrading IT infrastructure to enhance service quality and reliability[77]. - A new clinic was established in Kowloon and began operations in January 2024, contributing to the increase in medical services revenue[77]. - The group is exploring various potential projects related to its photography services business, aiming to diversify its business model and enhance its core operations[79]. - The group plans to continue evaluating the profitability of its photo booths and adjust their locations accordingly to optimize revenue generation[79]. - The company has actively sought to recruit suitable medical professionals and related equipment to further expand its medical services business[127]. Dividends and Shareholder Information - The company does not recommend the distribution of any interim dividend for the six months ended June 30, 2024[12]. - The company did not declare any interim dividend for the six months ended June 30, 2024, while a special dividend of HKD 4,500,000 was approved for the year ended December 31, 2023[54]. - As of June 30, 2024, Causeway Treasure holds 427,600,560 shares, representing approximately 53.45% of the company's equity[114]. - Both Mr. Chan Wing Chai and Mr. Chan Tin Ki own about 47.25% of Causeway Treasure, while Ms. Au Yeung Ying Ho holds approximately 5.5%[115]. Compliance and Governance - The audit committee, consisting of three independent non-executive directors, reviewed the unaudited consolidated results for the six months ending June 30, 2024[122]. - The company has established an audit committee in compliance with GEM listing rules to oversee financial reporting and risk management[122]. - There are no known interests or holdings in competing businesses by directors or major shareholders as of June 30, 2024[121]. - The company has not adopted any new accounting standards that would have a significant impact on its financial performance for the current period[34].

Revenue Performance - The group's revenue for the six months ended June 30, 2024, was approximately HKD 34,574,000, a decrease of about HKD 4,903,000 from HKD 39,477,000 for the same period in 2023, representing a decline of approximately 12.42%[3] - Revenue from the photography services segment decreased by approximately 29.50% to about HKD 23,441,000, down from HKD 33,249,000 in the previous year[3] - Revenue from the medical services segment increased by approximately 78.76% to about HKD 11,133,000, compared to HKD 6,228,000 for the same period in 2023[3] - Photography services revenue was HKD 23,441,000, down from HKD 33,249,000, while medical service revenue increased to HKD 11,133,000 from HKD 6,228,000[14] Profitability and Loss - The group's gross profit for the six months ended June 30, 2024, was approximately HKD 10,839,000, with a gross profit margin of about 31.35%, compared to HKD 13,056,000 and a margin of 33.07% in 2023[3] - The loss attributable to equity shareholders for the six months ended June 30, 2024, was approximately HKD 199,000, compared to a profit of HKD 3,708,000 for the same period in 2023[3] - The company reported a basic and diluted loss per share of HKD (0.02) for the six months ended June 30, 2024, compared to earnings of HKD 0.46 in 2023[5] - The company reported a net loss of HKD 199,000 for the period, compared to a loss of HKD 3,708,000 in the previous period[8] Comprehensive Income - Total comprehensive income for the six months ended June 30, 2024, was approximately HKD 434,000, significantly lower than HKD 4,084,000 for the same period in 2023[5] - The total comprehensive income for the period was HKD 434,000, compared to HKD 4,084,000 in the previous period, reflecting a significant decrease[8] Expenses and Costs - The administrative expenses for the six months ended June 30, 2024, were approximately HKD 10,188,000, compared to HKD 9,331,000 in 2023[4] - Total corporate and administrative expenses amounted to HKD 6,970,000, leading to a pre-tax profit of HKD 392,000 for the reporting period[16] - Total employee costs increased to 9,135,000 HKD for the six months ended June 30, 2024, up from 7,818,000 HKD in the same period of 2023, representing a rise of 16.8%[20] Assets and Liabilities - As of June 30, 2024, total non-current assets amounted to HKD 19,753,000, a decrease of 15.5% from HKD 23,175,000 as of December 31, 2023[6] - Current assets totaled HKD 30,200,000, slightly down from HKD 31,265,000, reflecting a decrease of 3.4%[6] - Total liabilities decreased to HKD 17,222,000 from HKD 16,020,000, indicating a rise of 7.5%[6] - The net asset value as of June 30, 2024, was HKD 12,978,000, down from HKD 15,245,000, a decline of 14.9%[6] - The company's total equity attributable to shareholders decreased to HKD 24,169,000 from HKD 28,686,000, a drop of 15.8%[7] Cash Flow - The net cash flow from operating activities for the first half of 2024 was HKD 6,292,000, down from HKD 6,496,000 in the previous year, reflecting a decrease of approximately 3.1%[9] - Cash and cash equivalents increased to HKD 24,919,000 at the end of June 2024, up from HKD 20,333,000 at the end of June 2023, representing a growth of approximately 22.5%[10] - The company reported a net cash used in financing activities of HKD 6,064,000 for the first half of 2024, compared to HKD 2,927,000 in the same period last year, indicating increased financing costs[10] Shareholder Information - The company did not recommend the payment of any interim dividend for the six months ended June 30, 2024[3] - The company declared a special dividend of HKD 4,500,000, impacting the equity attributable to shareholders[8] - As of June 30, 2024, directors and senior management hold approximately 53.45% of the company's shares through Causeway Treasure, which owns 427,600,560 shares[65] - Major shareholders include Causeway Treasure with 53.45% ownership (427,600,560 shares) and ME Group International Plc. with 13.75% ownership (109,972,500 shares) as of June 30, 2024[68] Strategic Developments - The group continues to focus on expanding its medical services in Hong Kong and enhancing its photography services in both Hong Kong and mainland China[16] - The group is reallocating resources to develop the medical services business, including purchasing equipment and upgrading IT systems to enhance service quality and reliability[40] - The company plans to establish or acquire new clinics and medical-related businesses to further expand its medical services operations[40] - The introduction of the non-Chinese citizen permit is expected to increase demand for identification photos, contributing additional revenue to the photography services business[38] Governance and Compliance - The company has maintained a high level of corporate governance, adhering to all applicable rules of the GEM listing[60] - The audit committee, consisting of three independent non-executive directors, has reviewed the unaudited consolidated results for the six months ended June 30, 2024, and found them to comply with applicable accounting standards and regulations[74]

Financial Performance - For the fiscal year ending December 31, 2023, the company reported a revenue increase of 156.7% to approximately HKD 80,218,000[10] - The profit attributable to equity shareholders rose by 166.5% to approximately HKD 7,658,000 for the same period[10] - Revenue from the photography services business reached approximately HKD 65,039,000, reflecting a growth of about 178.4%[12] - The medical services business generated revenue of approximately HKD 15,179,000, marking an increase of approximately 92.4%[14] - The company's revenue increased from approximately HKD 31,253,000 for the year ended December 31, 2022, to approximately HKD 80,218,000 for the year ended December 31, 2023, representing an increase of about 156.5%[32] - Photography services revenue rose approximately 178.4% to about HKD 65,039,000 for the year ended December 31, 2023, compared to HKD 23,362,000 for the previous year[32] - Medical services revenue increased to approximately HKD 15,179,000 for the year ended December 31, 2023, up from HKD 7,891,000 for the year ended December 31, 2022, reflecting a growth driven by increased patient visits[32] - The company's gross profit improved to approximately HKD 26,905,000 for the year ended December 31, 2023, with a gross profit margin of about 33.54%, compared to HKD 5,078,000 and a margin of 16.25% for the previous year[34] - Other income decreased from approximately HKD 2,073,000 for the year ended December 31, 2022, to about HKD 584,000 for the year ended December 31, 2023, primarily due to a reduction in rental revision income[35] - The company's profit attributable to owners increased from a loss of approximately HKD 11,518,000 for the year ended December 31, 2022, to a profit of approximately HKD 7,658,000 for the year ended December 31, 2023, primarily due to increased revenue from the Hong Kong photography services business[42] Business Strategy and Expansion - The company plans to establish or acquire new clinics and related medical businesses to expand its medical services portfolio[14] - The company is exploring various potential projects to enhance its photography services, including upgrading self-service photo booths and introducing IT infrastructure[12] - The board believes that further development of the medical services business is crucial for the company's diversification strategy[14] - The company plans to strengthen its photography services and expand its customer base while reallocating resources to develop its medical services business in response to the growing demand for healthcare[19] - The company is actively seeking to recruit suitable practitioners and establish new medical centers in Hong Kong, aligning with the government's primary healthcare blueprint[28] - The company aims to enhance its existing core businesses and explore new business opportunities for sustainable growth and shareholder value creation[29] - The company has established new medical centers in Hong Kong and is actively seeking suitable practitioners and equipment to expand its medical services[54] Dividends and Shareholder Returns - A special dividend of HKD 0.005625 per share, totaling HKD 4,500,000, has been proposed, pending approval at the upcoming annual general meeting[17] - The company has proposed an interim dividend of HKD 0.00375 per share, totaling HKD 3,000,000, which was approved by shareholders[63] - A special dividend of HKD 0.005625 per share, totaling HKD 4,500,000, is proposed for the year ending December 31, 2023, pending shareholder approval[63] - The board considers various factors, including financial performance and capital expenditure needs, before declaring dividends[122] Financial Position and Ratios - Total equity increased to approximately HKD 27,945,000 as of December 31, 2023, from HKD 22,714,000 as of December 31, 2022[47] - Cash and cash equivalents amounted to approximately HKD 25,669,000 as of December 31, 2023, compared to HKD 21,699,000 as of December 31, 2022[47] - The current ratio and quick ratio were 1.95 and 1.87, respectively, as of December 31, 2023, compared to 1.92 and 1.87 as of December 31, 2022[47] - The company had bank loans of approximately HKD 1,000,000 as of December 31, 2023, unchanged from the previous year[47] - The company's total liabilities to total assets ratio was 48.7% as of December 31, 2023, down from 51.5% as of December 31, 2022[48] Risks and Compliance - The company faces currency risk primarily from cash and bank balances denominated in USD and RMB, with no hedging agreements currently in place[57] - The company relies on a professional team for its medical services, and any failure to attract or retain qualified professionals could adversely affect its financial performance[91] - The company emphasizes the importance of its reputation in the medical services sector, which could be negatively impacted by any negligence or legal issues, affecting its business and financial status[92] - The company has complied with all relevant laws and regulations, with no significant violations reported that could impact its operations[95] Corporate Governance - The company has adopted a corporate governance code in compliance with GEM Listing Rules and has adhered to all applicable provisions during the year[180] - The board consists of three executive directors, one non-executive director, and three independent non-executive directors, complying with the GEM Listing Rules regarding board composition[187] - The board has adopted a diversity policy and aims to appoint a director of a different gender by December 31, 2024[191] - All independent non-executive directors have confirmed their independence according to GEM listing rules, ensuring effective governance[191] - The company provides necessary onboarding training for new directors to ensure understanding of operations and responsibilities[194] - The roles of the chairman and CEO are clearly separated, with distinct responsibilities assigned to each[195] Share Options and Ownership - The company aims to encourage contributions from qualified individuals through its share option plan, which was adopted on February 8, 2018[139] - The share option plan is designed to reward past contributions and retain experienced personnel within the group[139] - The maximum number of shares to be issued under the share option plan shall not exceed 10% of the total issued shares at any time[142] - The total number of shares to be issued due to the exercise of all options granted to any eligible person within any 12-month period shall not exceed 1% of the total issued shares[145] - The beneficial ownership of Causeway Treasure is divided among Chen Yongji (47.25%), Chen Tianqi (47.25%), and Ouyang Yinghe (5.5%) as of December 31, 2023[136] Stakeholder Relationships - The group maintains strong relationships with key stakeholders, including employees, customers, and suppliers, with no significant disputes reported as of December 31, 2023[98] - The group does not rely on any single customer for its photography and medical services, ensuring a diversified customer base[103] - The group regularly reviews employee benefits and complies with local labor laws, providing medical insurance and other benefits[98] Auditor and Compliance - The auditor, KPMG, resigned on November 7, 2023, and the board appointed another firm to fill the vacancy[176] - The independent non-executive directors have reviewed the continuing connected transactions and confirmed that they were conducted under fair and reasonable terms, aligning with the overall interests of shareholders[162] - The auditor has stated that there are no matters of concern regarding the continuing connected transactions, which were established in accordance with regulatory agreements[163]

Financial Performance - For the fiscal year ending December 31, 2023, the total revenue was HKD 80,218 thousand, a significant increase from HKD 31,253 thousand in the previous year, representing a growth of approximately 156%[3] - The operating profit for the year was HKD 9,090 thousand, compared to a loss of HKD 12,049 thousand in the previous year, indicating a turnaround in operational performance[3] - The net profit for the year was HKD 8,019 thousand, recovering from a loss of HKD 12,383 thousand in the previous year, showcasing a substantial improvement in profitability[3] - The basic and diluted earnings per share for the year were HKD 0.96, compared to a loss of HKD 1.44 in the previous year, reflecting a positive shift in earnings[10] - The company reported a total comprehensive income of HKD 8,231 thousand for the year, recovering from a loss of HKD 11,833 thousand in the previous year[10] - The group reported a pre-tax loss of HKD 12,503,000 for the year ended December 31, 2022, compared to a pre-tax profit of HKD 8,431,000 for the year ended December 31, 2023[30] - The company reported a basic earnings per share of 9.57 HKD for 2023, compared to a loss of 14.39 HKD in 2022, indicating a significant recovery in profitability[47] - The company reported a profit attributable to owners of the company of approximately HKD 7,658,000 for the year ending December 31, 2023, an increase of about HKD 19,176,000 from a loss of HKD 11,518,000 in the previous year, primarily due to increased revenue from photography services in Hong Kong[140] Revenue Breakdown - Total revenue for the year ended December 31, 2023, was HKD 80,218,000, with a breakdown of HKD 63,830,000 from photography services in Hong Kong, HKD 1,209,000 from services in mainland China, and HKD 15,179,000 from medical services in Hong Kong[132] - Photography services revenue increased by approximately 178.4% to about HKD 65,039,000 for the year ended December 31, 2023, compared to HKD 23,362,000 for the year ended December 31, 2022[69] - Medical services revenue was approximately HKD 15,179,000 for the year ended December 31, 2023, up from HKD 7,891,000 for the year ended December 31, 2022, due to an increase in patient visits[69] - The group's total revenue from external customers in Hong Kong was HKD 79,009,000, compared to HKD 30,313,000 in 2022[152] Cost and Expenses - The group reported a significant increase in cost of services to HKD 39,374,000 for the year ended December 31, 2023, compared to HKD 18,155,000 for the year ended December 31, 2022[45] - The group's service costs increased from approximately HKD 26,175,000 for the year ended December 31, 2022, to approximately HKD 53,313,000 for the year ended December 31, 2023, representing an increase of about 102%[70] - Administrative expenses increased from approximately HKD 16,596,000 for the year ended December 31, 2022, to approximately HKD 18,273,000 for the year ended December 31, 2023, an increase of about 10%[80] - The group incurred total employee benefit expenses of HKD 15,529,000 for the year ended December 31, 2023, up from HKD 12,078,000 in the previous year[36] Assets and Liabilities - The total assets of the company amounted to HKD 38,420 thousand, up from HKD 33,143 thousand in the previous year, reflecting growth in asset base[5] - The total equity of the group was approximately HKD 27,945,000, an increase from HKD 22,714,000 as of December 31, 2022, representing a growth of 22.3%[91] - The group's total assets as of December 31, 2023, amounted to HKD 54,440,000, compared to HKD 46,792,000 in the previous year[151] - The company’s non-current assets increased to 3,239,000 HKD in 2023 from 1,548,000 HKD in 2022, reflecting growth in long-term investments[52] Cash Flow and Liquidity - Cash and bank balances increased to HKD 20,669 thousand from HKD 16,699 thousand, indicating improved liquidity[5] - The group's cash and cash equivalents totaled approximately HKD 25,669,000 as of December 31, 2023, compared to HKD 21,699,000 as of December 31, 2022, reflecting a 18.5% increase[91] - The current ratio and quick ratio as of December 31, 2023, were 1.95 and 1.87, respectively, compared to 1.92 and 1.87 as of December 31, 2022, indicating stable liquidity management[91] - The group maintained a healthy financial position with bank loans of approximately HKD 1,000,000 as of December 31, 2023, consistent with the previous year[89] Dividends and Shareholder Returns - The group proposed a special dividend of HKD 0.5625 per share, totaling HKD 4,500,000, subject to shareholder approval[41] - The company declared an interim dividend of 0.375 HKD per share for 2023, compared to no dividend in 2022, signaling a return to shareholder rewards[46] - The board proposed a special dividend of HKD 0.005625 per share, subject to approval at the upcoming annual general meeting[140] Business Strategy and Future Plans - The company aims to expand its market presence and enhance its service offerings, focusing on both domestic and international markets[16] - The company is committed to ongoing research and development of new products and technologies to drive future growth[16] - The group is actively seeking to recruit suitable medical professionals and establish new medical centers in Hong Kong to expand its medical services business[66] - The group aims to diversify its business model by optimizing its operations through increased investment in information technology infrastructure[64] - The group recognizes significant expansion potential in the medical and healthcare services sector and intends to collaborate with the Hong Kong government and stakeholders to support a sustainable healthcare system[67] Risks and Compliance - The group faces currency risk primarily from cash and bank balances denominated in USD and RMB, with no hedging instruments currently in place[102] - The company has adhered to all applicable corporate governance code provisions as of December 31, 2023[118] - The company has maintained compliance with the GEM Listing Rules regarding director transactions as of December 31, 2023[121] Miscellaneous - The group successfully won a tender to provide automatic photography services for identity documents in Hong Kong, effective from March 1, 2023, for a period of 24 months[63] - The group plans to allocate resources to upgrade and maintain its automatic photography machines and enhance advertising and promotional activities[64] - The company operates primarily in providing photography services through self-service identity photo booths in Hong Kong and Guangdong Province, China, and has been offering medical services since October 2021[146]

Revenue Growth - The group's revenue increased from approximately HKD 20,154,000 for the nine months ended September 30, 2022, to approximately HKD 61,508,000 for the nine months ended September 30, 2023, representing an increase of about 205%[21]. - For the nine months ended September 30, 2023, the company's revenue was HKD 61,508,000, representing a significant increase from HKD 20,154,000 in the same period of 2022, which is a growth of approximately 205%[43]. - The group reported a total revenue of HKD 61,508,000 for the nine months ended September 30, 2023, compared to HKD 20,154,000 for the same period in 2022, representing a growth of 205%[72]. Photography Services - Photography service revenue surged approximately 236% to about HKD 51,615,000 for the nine months ended September 30, 2023, compared to HKD 15,360,000 for the same period in 2022[21]. - Photography service revenue in Hong Kong reached HKD 51,615,000, up from HKD 15,360,000 in the previous year, indicating a significant increase of 236%[72]. - The company has successfully tendered for a contract to provide automatic photography services for identity documents in Hong Kong, effective from March 1, 2023, for a duration of 24 months[107]. Medical Services - Medical services revenue reached approximately HKD 9,893,000 for the nine months ended September 30, 2023, marking an increase of about 106% from HKD 4,794,000 for the same period in 2022, primarily due to an increase in patient visits[21]. - Medical service revenue in Hong Kong was HKD 9,893,000, compared to HKD 4,794,000 in the prior year, reflecting a growth of 64%[72]. - The group is actively seeking opportunities to expand its medical services by establishing new medical centers in Hong Kong, with new lease agreements signed with independent third parties[59]. Profitability - The group's gross profit for the nine months ended September 30, 2023, was approximately HKD 20,776,000, with a gross profit margin of about 33.78%, compared to a gross profit of HKD 1,101,000 and a margin of 5.46% for the same period in 2022[21]. - The profit attributable to equity shareholders increased from a loss of approximately HKD 8,508,000 for the nine months ended September 30, 2022, to a profit of approximately HKD 6,694,000 for the same period in 2023[21]. - Operating profit for the nine months ended September 30, 2023, was HKD 7,332,000, a turnaround from an operating loss of HKD 8,909,000 in the previous year[43]. Comprehensive Income - The total comprehensive income for the nine months was HKD 7,196,000, a significant improvement from a total comprehensive loss of HKD 8,601,000 in the previous year[45]. - The group reported a total comprehensive income of HKD 7,196,000 for the nine months, compared to a loss of HKD 8,601,000 in the previous year[62]. Dividends and Utilization of Proceeds - The company does not recommend the declaration of any interim dividend for the nine months ended September 30, 2023[21]. - As of September 30, 2023, the company had unutilized net proceeds of approximately HKD 12,756,000, with expected full utilization by December 31, 2024[5]. - The company plans to upgrade its verification center and IT infrastructure with an allocation of HKD 2,000,000, expected to be fully utilized by December 31, 2024[5]. Expenses and Financial Management - Administrative expenses rose from approximately HKD 12,591,000 for the nine months ended September 30, 2022, to about HKD 13,715,000 for the same period in 2023, mainly due to increased employee costs and travel expenses[116]. - The group incurred a total corporate expenses of HKD 9,265,000 during the reporting period[57]. - The company maintains an appropriate level of cash and cash equivalents to manage liquidity risks effectively[167]. Future Plans and Investments - The company aims to establish or acquire new clinics and related medical services, with an allocation of HKD 2,000,000, also expected to be fully utilized by December 31, 2024[5]. - The company is exploring new business opportunities and optimizing its business model through increased investment in IT infrastructure[108]. - The company plans to reallocate unutilized funds from its expansion plans to develop its self-service identity photo digital camera business in Hong Kong and acquire new clinics and medical services[164]. Compliance and Governance - The company has maintained compliance with all applicable corporate governance codes as of September 30, 2023[37]. - The audit committee, consisting of three independent non-executive directors, has reviewed the unaudited consolidated results for the nine months ended September 30, 2023, and confirmed compliance with applicable accounting standards and GEM listing rules[191].

香港交易及結算所有限公司及香港聯合交易所有限公司（「聯交所」）對本 公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確 表示概不就因本公告全部或任何部分內容而產生或因倚賴該等內容而引 致的任何損失承擔任何責任。 本公告的資料乃遵守聯交所GEM證券上市規則（「GEM上市規則」）而刊載， 旨在提供有關名仕快相集團控股有限公司（「本公司」，連同其附屬公司為「本 集團」或「我們」）的資料；本公司董事（「董事」）願就本公告的資料共同及個 別地承擔全部責任。各董事於作出一切合理查詢後，確認就其所深知及 確信，本公告所載資料於各重大方面均屬準確完備，沒有誤導或欺詐成分， 且並無遺漏任何其他事項，足以令致本公告所載任何陳述或本公告產生 誤導。 Max Sight Photo (cid:8907)(cid:7571)(cid:11945)(cid:17846) Max Sight Group Holdings Limited 名 仕 快 相 集 團 控 股 有 限 公 司 （於開曼群島註冊成立的有限公司） （股份代號：8483） 截 至 二 零 二 三 年 九 月 三 十 日 止 九 個 月 第 三 季 度 業 績 ...

接 千透元 千港元 千禧元 千港元 千港元 千穂元 千港元 千穂元 龄二零二二年一月一日 (授賽技) 8,000 53,083 [1,089] (5,664) (19,546) 34,784 (242) 34,542 度内新損 - - - - (6,434) (6,434) (541) (6,974) 其他全面教崔 - - 272 . - 272 - 272 全面收益總额 - - - (15,162) 272 [6,434] (541) (16,702) 养控股股東注資 - - - 於二零二三年六月三十日·本集團的銀行融資以賬面總值為5,000,000港元的受限制銀行 存款作抵押(二零二二年六月三十日：無)。 有關資料載於本中期報告的未經審核簡明綜合財務報表附註9。 中期股息 董事及最高行政人員於股份、相關股份及債權證的權益及淡倉 於二零二三年六月三十日·董事及本公司最高行政人員於本公司或其相聯法團(定義見 證券及期貨條例第XV部)的股份、相關股份及債權證中,擁有(I)根據證券及期貨條例第 XV部第7及8分部須知會本公司及聯交所的權益及淡倉(包括根據證券及期貨條例有關條 文彼等被當作或被視為擁有的權益及淡倉) ...

香港交易及結算所有限公司及香港聯合交易所有限公司（「聯交所」）對本 公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確 表示概不就因本公告全部或任何部分內容而產生或因倚賴該等內容而引 致的任何損失承擔任何責任。 本公告的資料乃遵守聯交所GEM證券上市規則（「GEM上市規則」）而刊載， 旨在提供有關名仕快相集團控股有限公司（「本公司」）（連同其附屬公司， 統稱「本集團」或「我們」）的資料；本公司董事（「董事」）願就本公告的資料 共同及個別地承擔全部責任。各董事於作出一切合理查詢後，確認就其 所深知及確信，本公告所載資料於各重大方面均屬準確完備，沒有誤導 或欺詐成分，且並無遺漏任何其他事項，足以令致本公告所載任何陳述 或本公告產生誤導。 Max Sight Photo (cid:8907)(cid:7571)(cid:11945)(cid:17846) Max Sight Group Holdings Limited 名 仕 快 相 集 團 控 股 有 限 公 司 （於開曼群島註冊成立的有限公司） （股份代號：8483） 截 至 二 零 二 三 年 六 月 三 十 日 止 六 個 月 中 期 業 績 ...